Glaxo ordered to pay compensation for alleged Paxil defects

GlaxoSmithKline, the world's second-biggest drugmaker, was ordered in Philadelphia court today to pay compensatory damages over claims that its antidepressant, Paxil, causes birth defects. This case marks the first time a jury has considered claims that the drug manufacturer knew Paxil caused birth defects and hid the risk in order to increase profits.

Read the article featured by

Read more about litigation involving potentially dangerous drugs.